Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer  by Murchison, Elizabeth P. et al.
Genome Sequencing and Analysis
of the Tasmanian Devil
and Its Transmissible Cancer
Elizabeth P. Murchison,1,* Ole B. Schulz-Trieglaff,2 Zemin Ning,1 Ludmil B. Alexandrov,1 Markus J. Bauer,2 Beiyuan Fu,1
Matthew Hims,2 Zhihao Ding,1 Sergii Ivakhno,2 Caitlin Stewart,1 Bee Ling Ng,1 Wendy Wong,2 Bronwen Aken,1
Simon White,1 Amber Alsop,3 Jennifer Becq,2 Graham R. Bignell,1 R. Keira Cheetham,2 William Cheng,1
Thomas R. Connor,1 Anthony J. Cox,2 Zhi-Ping Feng,4,5 Yong Gu,1 Russell J. Grocock,2 Simon R. Harris,1
IrinaKhrebtukova,6ZoyaKingsbury,2MarkKowarsky,4AlexandreKreiss,7ShujunLuo,6 JohnMarshall,1DavidJ.McBride,1
Lisa Murray,2 Anne-Maree Pearse,8 Keiran Raine,1 Isabelle Rasolonjatovo,2 Richard Shaw,2 Philip Tedder,2
Carolyn Tregidgo,2 Albert J. Vilella,9 David C. Wedge,1 Gregory M. Woods,7 Niall Gormley,2 Sean Humphray,2
Gary Schroth,6 Geoffrey Smith,2 Kevin Hall,2 Stephen M.J. Searle,1 Nigel P. Carter,1 Anthony T. Papenfuss,4,10
P. Andrew Futreal,1 Peter J. Campbell,1 Fengtang Yang,1 David R. Bentley,2 Dirk J. Evers,2 and Michael R. Stratton1,*
1Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK
2Illumina Cambridge Ltd., Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK
3Comparative Genomics Group, Research School of Biological Sciences, Australian National University, Canberra 2601, Australia
4Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia
5Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia
6Illumina Hayward, 25861 Industrial Boulevard, Hayward, CA 94545, USA
7Menzies Research Institute Tasmania, University of Tasmania, Private Bag 23, Hobart, Tasmania 7001, Australia
8Animal Health Laboratory, Department of Primary Industries, Parks, Water and Environment, PO Box 46, Kings Meadows,
Tasmania 7249, Australia
9European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK
10Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria 3010, Australia
*Correspondence: mrs@sanger.ac.uk (M.R.S.), elizabeth.murchison@sanger.ac.uk (E.P.M.)
DOI 10.1016/j.cell.2011.11.065
Open access under CC BY license.SUMMARY
The Tasmanian devil (Sarcophilus harrisii), the largest
marsupial carnivore, is endangereddue toa transmis-
sible facial cancer spread by direct transfer of living
cancer cells through biting. Here we describe the
sequencing, assembly, and annotation of the Tasma-
nian devil genome and whole-genome sequences for
two geographically distant subclones of the cancer.
Genomic analysis suggests that the cancer first arose
from a female Tasmanian devil and that the clone has
subsequently genetically diverged during its spread
across Tasmania. The devil cancer genome contains
more than 17,000 somatic base substitution muta-
tions and bears the imprint of a distinct mutational
process. Genotyping of somatic mutations in 104
geographically and temporallydistributedTasmanian
devil tumors reveals the pattern of evolution and
spread of this parasitic clonal lineage, with evidence
of a selective sweep in one geographical area and
persistence of parallel lineages in other populations.INTRODUCTION
Cancers are clonal cell lineages that arise due to somatic
changes that promote cell proliferation and survival. Although780 Cell 148, 780–791, February 17, 2012 ª2012 Elsevier Inc.natural selection operating on cancers favors the outgrowth of
malignant clones with replicative immortality, the continued
survival of a cancer is generally restricted by the life span of its
host. Tasmanian devil facial tumor disease (DFTD) is an unusual
cancer that has survived beyond the death of the individual that
spawned it by acquiring adaptations for transmission between
hosts. This cancer has spread through the Tasmanian devil
population and is threatening the species with extinction (Haw-
kins et al., 2006; McCallum et al., 2009). The genomes of the
Tasmanian devil and its transmissible cancer, DFTD, are thus
of interest both from the perspective of conservation of a threat-
ened species as well as for the insights they may provide into
the origins, somatic evolution and population genetics of an
extraordinarily divergent neoplastic clonal lineage.
The Tasmanian devil (Sarcophilus harrisii) is a marsupial carni-
vore endemic to the island of Tasmania, Australia. Tasmanian
devils are solitary nocturnal scavengers that weigh up to 12 kg
and generally live for 5 or 6 years in the wild (Owen and Pember-
ton, 2005). They are seasonal breeders and females rear
a maximum of four pouch young each year (Owen and Pember-
ton, 2005). The species has limited genetic diversity, although
three genetically distinct geographically defined subpopulations
have been described (Jones et al., 2004; Miller et al., 2011).
DFTD was first observed in northeastern Tasmania in 1996
(Hawkins et al., 2006). The disease is characterized by the
appearance of tumors, usually on the face and inside the mouth
of affected animals, which frequently metastasise and usually
cause death within months (Figure 1) (Hawkins et al., 2006;
Figure 1. Tasmanian Devil Facial Tumor Disease
Tasmanian devil facial tumor disease (DFTD) is a single cancer lineage spread
by the horizontal transfer of living cancer cells.Lachish et al., 2007; Loh et al., 2006a). Most commonly observed
in sexually mature individuals of 2 years or older, DFTD occurs
equally in male and female devils (Hawkins et al., 2006; Loh
et al., 2006a). The cancer has spread rapidly through the Tasma-
nian devil population and has been associated with devil
population decline (Hawkins et al., 2006; Lachish et al., 2007).
Epidemiological studies have documented the expansion of
the disease down the east coast of Tasmania and its continuing
progression toward thewest coast (Hawkins et al., 2006; Lachish
et al., 2007).
DFTD spreads by the direct transfer of living cancer cells,
usually through bites inflicted on the face during mating and
feeding interactions (Hamede et al., 2008; Pearse and Swift,
2006). DFTD is believed to be of neural crest origin, and the
cancer cells express a number of genes of the Schwann cell
lineage (Loh et al., 2006b; Murchison et al., 2010). The mecha-nism whereby the clone avoids immune rejection during coloni-
zation of allogeneic hosts remains unknown. Although low
genetic diversity may contribute to DFTD susceptibility, experi-
ments have indicated that devils are normally capable of
mounting immune reactions to allogeneic grafts (Kreiss et al.,
2011; Siddle et al., 2007).
DFTD is one of two known naturally occurring clonally trans-
missible cancers, the other being the canine transmissible
venereal tumor (CTVT) of dogs (Murchison, 2009). CTVT is a
sexually transmitted lineage that is found around that world
and that may have first arisen thousands of years ago from the
cells of a wolf or East Asian breed of dog (Murgia et al., 2006;
Rebbeck et al., 2009). Genetic analysis of the global diversity
of CTVT cancers has indicated that the lineage has achieved
considerable heterogeneity, with substantial lineage diversity
present worldwide (Murgia et al., 2006; Rebbeck et al., 2009).
Divergence time estimates suggest that modern CTVT may
represent a recent global sweep of an ancient lineage (Rebbeck
et al., 2009). In contrast to CTVT, little is known of the population
diversity of DFTD or the dynamics of its spread through its host
population.
Cancer genomes are characterized by somatic changes
including single-base substitution mutations, small insertions
and deletions (indels), structural rearrangements, and copy
number alterations. Analysis of the catalog of somatic mutations
in cancer genomes can lead to greater understanding of the
mutational events that triggered clonal outgrowth and the expo-
sures or DNA repair defects that were responsible for the
mutations in the first place (Pleasance et al., 2010a, 2010b).
DFTD is a transmissible clone that has spread through the devil
population in a process similar tometastasis. Its widely divergent
lineage as a malignant clone make it an almost unique model
for studying the genomic stability and long term evolution of
cancer cells.
We have sequenced, assembled, and annotated the normal
genome of the Tasmanian devil, and we have used this reference
to analyze the genomes of a second normal Tasmanian devil and
two geographically distant DFTD cancer subclones. In addition,
we have analyzed the genetic diversity present in 104 DFTD
tumors collected from distant locations throughout Tasmania
over a period of 7 years. Our analysis has led to the identification
of genetic features of the original devil that gave rise to DFTD,
a description of the underlying mutational processes that have
characterized DFTD progression, annotation of gene variants
that may have contributed to DFTD pathogenesis, and a map
of the clonal dynamics of the disease during its spread through
Tasmania.
RESULTS
The Tasmanian Devil Genome
To generate a reference genome for the Tasmanian devil, we
sequenced and assembled the genome of a 5-year-old female
Tasmanian devil. Sequencing libraries were prepared from
genomic DNA extracted from a cell line derived from normal
fibroblasts. These were sequenced from both ends, yielding
2.87 3 109 pairs of 100 bp sequence reads. Additional ‘‘mate
pair’’ libraries, producedbycircularisinggenomicDNA fragmentsCell 148, 780–791, February 17, 2012 ª2012 Elsevier Inc. 781
Table 1. Tasmanian Devil Genome Assembly Features
Contigs Supercontigs
Total number 237,291 35,974
Total number of bases 2.93 Gb 3.17 Gb
N50 contig/supercontig size 20,139 bp 1,847,186 bp
Largest contig/supercontig 189,866 bp 5,315,556 bp
Average size 12,354 bp 88,254 bp
See also Table S1 and Figure S1 for further details of Tasmanian devil
genome size estimates and Table S2 for a summary of in silico chromo-
some assignment.of between 3 kilobase pairs (kb) and 10 kb in length, were gener-
ated and 50 bp was sequenced from both ends in order to assist
with genome assembly.
The genome was assembled with the Phusion2 assembly
pipeline (Mullikin and Ning, 2003), and assembly features are
summarized in Table 1. We estimated the size of the Tasmanian
devil genome to be between 2.89 and 3.17 gigabase pairs (Gb)
using both sequencing and flow cytometry data (Table S1 and
Figure S1 available online). This is comparable with previous
estimates of the Tasmanian devil and other marsupial genome
sizes (Mikkelsen et al., 2007; Miller et al., 2011; Renfree et al.,
2011). The Tasmanian devil genome has a G+C content of
36.4%, similar to that of the opossum (37.8%) but lower than
that of humans (45.2%).
To determine the chromosomal locations of our assembled
contigs, we individually sorted each of the seven Tasmanian
devil chromosomes from the female devil fibroblast cell line
using a flow cytometer. Fifty thousand copies of each devil
chromosome were collected, amplified, and sequenced. Align-
ment of the chromosome reads with the assembled contigs
was used to assign the contigs to chromosomes; in addition,
this method was used to detect and correct assembly errors
by identifying contigs with homology to more than one chromo-
some. Using this method, we were able to assign 35,534
supercontigs (99%) to chromosomes. The number of bases
assigned to each chromosome correlated with the flow cytome-
try measurement of chromosome DNA content (Table S2).
Tasmanian devil chromosomes were named according to the
system described by Pearse and Swift (Pearse and Swift,
2006), which differs in the naming of chromosomes 1 and 2 to
a previous karyotype nomenclature for devils (Eldridge and Met-
calf, 2006; Martin and Hayman, 1967). We used cross-species
chromosome painting to determine the homology between
devil and opossum chromosomes (Figure S2). We then used
conservation with the opossum genome as a template for
ordering supercontigs on each devil chromosome.
Tasmanian devil genes were identified using the Ensembl
genome annotation pipeline (Curwen et al., 2004; Potter et al.,
2004), modified to incorporate devil transcriptome data. In total
18,775 protein-coding gene models were constructed, 1,213
of which did not have orthologs in the human or opossum
genomes.We specifically searched the Tasmanian devil genome
for a set of 451 genes that have been causally linked with cancer
in humans (Futreal et al., 2004). Orthologs for 398 of these
genes could be detected in the Tasmanian devil genome. Three782 Cell 148, 780–791, February 17, 2012 ª2012 Elsevier Inc.hundred sixty-three microRNAs (miRNAs) were annotated in
the Tasmanian devil genome by aligning small RNA sequence
reads (Murchison et al., 2010). One hundred nineteen predicted
miRNAs were devil orthologs of previously identified miRNAs
and 244 were predicted novel miRNAs.
Tasmanian Devil Cancer Genome Landscape
We conducted cytogenetic analyses and sequenced the
genomes of two DFTD cell lines, 87T and 53T, from geographi-
cally different regions of Tasmania (Figure 2A). 87T is derived
from a tumor from a devil captured in 2007 in southeast Tasma-
nia, and 53T was established in 2007 from a lung metastasis in
a devil from the north coast of Tasmania.
Alignment of the DFTD cancer cell line genomes with the
reference genome yielded 691,328 and 699,156 single base
substitutions in 87T and 53T, respectively, and 317,240 and
307,613 indels in 87T and 53T, respectively (Figure 2B). The
number of variants in the DFTD genomes was somewhat higher
than the number of variants observed in the normal female devil,
and in a second normal male genome sequenced to assess
normal variation (Figure 2B). This is not surprising, given that
the DFTD genome contains variants that were present in the
constitutional genome of the devil that first gave rise to the
DFTD clone (the founder devil), as well as somatic variants that
have arisen since DFTD has been a malignant clonal lineage
(Figure 2B). These estimates are consistent with previous studies
(Miller et al., 2011). Cytogenetic analyses indicated that the
two DFTD subclones have differences in their karyotypes
(Figure 2A). 87T is pseudodiploid with 13 chromosomes,
whereas 53T is pseudotetraploid with 32 chromosomes. We
used labeled flow-sorted chromosomes derived from a normal
devil cell line as probes for forward chromosome painting of
87T. This experiment revealed several cytogenetic changes in
DFTD (Figures 2C and 2D). Reverse chromosome painting, using
labeled DNAs derived from flow-sorted chromosomes from
87T, provided further insights into the translocations in 87T
and revealed heterozygous deletions on chromosomes 1, 2,
and 3, as well as trisomy 5p (Figure 2E). Copy number analysis
indicated that 87T has few detectable hemizygous deletions
and no detectable high-level amplifications (Figure 2F and
Figure S3).
These analyses indicate that the DFTD genome contains
substitutions, indels, copy number changes, and rearrange-
ments. We next devised methods to identify subsets of variants
of germline origin (i.e., those that were present in the constitu-
tional genome of the founder devil) and those of somatic origin
(i.e., those that arose during clonal proliferation of the DFTD
lineage) in order to investigate the origin and somatic evolution
of the DFTD clone.
Origin of DFTD
DFTD was first observed in 1996 in northeast Tasmania (Haw-
kins et al., 2006). Previous studies have indicated that the
cancer is derived from the cells of one devil (the DFTD founder),
and has subsequently spread through the devil population
as a clone (Pearse and Swift, 2006). We do not have DNA
from the founder’s normal genome, as this animal was a wild
Tasmanian devil that lived and probably died prior to 1996.
Figure 2. Variation in Tasmanian Devil Normal and Cancer Genomes
(A) Location, year of isolation, and karyotypes for 87T and 53T DFTD cancer cell lines.
(B) Four genomes were sequenced in this study, two normal Tasmanian devil genomes (female and male) and two DFTD cancer genomes (87T and 53T). DFTD
originated in the DFTD founder devil, and 87T and 53T are both clonally derived from their most recent common ancestor tumor (the progenitor tumor). The female
normal sequencewas used to assemble the Tasmanian devil reference genome. The number of substitutions and indels comparedwith the reference sequence is
indicated for each genome. The number of variants that were unique to each genome is indicated in brackets. The number of variants in the most recent common
ancestor tumor was inferred using the variants that were common between 87T and 53T.
(C) Forward chromosome painting for the normal female fibroblast cell line carrying trisomy 6 that was used to generate the reference genome assembly.
* indicates a region of overlap between chromosomes 1 and 2 that was present in the metaphase image that was used to generate the karyotype. Cytogenetic
comparison between Tasmanian devil and opossum is summarized in Figure S2.
(D) Forward chromosome painting for the 87T DFTD tumor.
(E) Reverse painting was performed by flow sorting 87T chromosomes to produce paints (labeled A to G and I to M) and hybridizing these with normal Tasmanian
devil metaphases. The F paint includes two similarly sized 87T chromosomes that we were unable to separate with flow cytometry.
(F) Summary of copy number variation in 87T DFTD genome (including only changes >10Mb in size). See Figure S3 for complete 87T and 53T copy number data.
See also Figures S2 and S3.However, variants from this devil’s constitutional genome
remain within the DFTD cells that make up the tumors of thou-
sands of devils.
We sought to reconstruct the genome of the founder devil by
searching for common variants between the genomes of the
two DFTD subclones, 87T and 53T. These variants will include
normal variation that was present in the founder’s genome as
well as somatic variants in DFTD that arose prior to divergence
of the 87T and 53T lineages. We found 700,436 common singlebase substitutions and 251,257 common indels between 87T
and 53T (Figure 2B). At least 563,877 single-base substitution
variants and 235,610 indels are likely to be the founder’s germ-
line variants, as we also found them in either the female or
male normal devil genomes. The remaining 136,559 substitu-
tions and 14,647 indels will include private germline variants
that were specific to the founder devil and not found in the two
normal genomes that we sequenced as well as somatic muta-
tions that have been acquired by the DFTD lineage.Cell 148, 780–791, February 17, 2012 ª2012 Elsevier Inc. 783
Figure 3. DFTD Origin
(A) Y chromosome gene SRY is not detectable in DFTD using PCR. Primer sequences are available (Lachish et al., 2011; Murchison et al., 2010).
(B) Number of X chromosome variants in female andmale normal devil genomes and 87T and 53T DFTD genomes. Variants from a poorly assembled region at the
end of chromosome X were excluded from this analysis.
(C) Phylogenetic tree of devil mitochondrial variation. Each dot on the map indicates an individual devil and the color of the dot represents the mitochondrial
haplotype for each devil. Each haplotype is also represented on the phylogenetic tree. DFTD mitochondrial haplotypes are indicated in gray; some DFTD tumors
also had the haplotype represented by the red dot.
See also Figure S3 for chromosome X copy number plots for 87T and 53T.The gender of the founder devil is unknown. Like other marsu-
pials, Tasmanian devils have X and Y sex chromosomes, and
males are the heterogametic sex. Previous studies have indi-
cated that neither of the sex chromosomes is cytogenetically
identifiable in DFTD (Pearse and Swift, 2006). It is possible
that the sex chromosomes initially present in the constitutional
genome of the founder devil have been lost during DFTD
carcinogenesis or that these chromosomes have been rear-
ranged in the DFTD genome such that they are not cytogeneti-
cally identifiable. We first searched for the presence of the Y
chromosome gene SRY in DFTD. As expected, the SRY gene
could be amplified from the genome of a male devil but not
from a female devil; however, our assays could not detect
SRY in the DFTD genome (Figure 3A). We next searched for
evidence of the X chromosome in the DFTD genome. Reverse
chromosome painting experiments and copy number analysis
of 87T indicated that the X chromosome is present in approxi-
mately two copies in this genome (Figure 2 and Figure S3).
These are likely to be a homologous pair rather than recent
duplicates, as the number of single-base substitution variants
mapping to the X chromosome in the two DFTD genomes was
comparable to the number of variants found on the X chromo-
some in the female normal devil genome and approximately
double the number of X chromosome variants found in the
male normal genome (Figure 3B). The data therefore suggest
that the DFTD founder devil was a female.784 Cell 148, 780–791, February 17, 2012 ª2012 Elsevier Inc.DFTD was first observed in northeast Tasmania (Hawkins
et al., 2006). To explore further the geographic origin of the
founder devil we sequenced the mitochondrial genomes
(excluding the control region) of 92 Tasmanian devils from 25
locations in Tasmania and constructed a phylogenetic tree
based on their sequences (Figure 3C). We found evidence for
six mitochondrial haplotypes among normal devils. Three of
these had widespread distributions throughout Tasmania and
three were confined to locations in the northwest of Tasmania,
consistent with other studies (Miller et al., 2011). The 87T and
53T DFTD mitochondrial genomes were most closely related to
one of the widespread devil haplotypes.
There is evidence of horizontal transfer of mitochondrial
genomes between hosts and cancers in another transmissible
cancer lineage, CTVT, which has led to multiple distinct clades
of CTVT mitochondrial haplotypes (Rebbeck et al., 2011). To
test whether horizontal transfer of mitochondria occurs in
DFTD, we sequenced the mitochondrial genomes of 104 DFTD
tumors and included their haplotypes on the phylogenetic tree
(Figure 3C). All of the DFTD mitochondria were either identical
to or apparently derived from a single devil haplotype, suggest-
ing that they are clonally derived from the founder devil. These
analyses suggest that mitochondrial horizontal transfer does
not occur or is not widespread in DFTD, and indicate that the
founder devil belonged to a haplogroup that is currently wide-
spread throughout Tasmania.
DFTD was first observed in 1996 (Hawkins et al., 2006).
However, we do not know the timing of the emergence of the
DFTD clone. Given the overt and disfiguring symptoms of
DFTD, as well as its dramatic recent effects on devil population
size (Hawkins et al., 2006; Lachish et al., 2007), it seems unlikely
that the disease remained undetected for a long period prior to
1996. Indeed, retrospective studies of devil skulls, preserved
specimens and pelts collected between 1941 and 1989 revealed
no evidence for DFTD prior to the 1990s (Loh et al., 2006a).
However, it is possible that the current DFTD epidemic is the
most recent manifestation of an ancient clone with a long history
of coexistence with the Tasmanian devil population. Our mito-
chondrial genome analysis indicates that the founder devil’s
mitochondrial genome is identical to those found in many
modern devils (Figure 3C). In addition, DFTD mitochondrial
genomes are in most cases more closely related to the founder
than to each other (Figure 3C). These observations are consis-
tent with a recent origin for DFTD.
Somatic Evolution of DFTD
Having identified genetic features and variants present in the
constitutional genome of the DFTD founder devil, we next
performed a detailed analysis of DFTD variants of somatic
origin. Somatic variants are those that have arisen during the
establishment and progression of DFTD as a clonal lineage.
Analysis of somatic variants in two divergent DFTD lineages
may provide insight into the mutational processes that have
operated in DFTD as well as the genetic changes that have
driven its growth.
We cannot directly ascertain the set of somatic variants
in DFTD because the founder devil died in obscurity in the
Tasmanian bush more than a decade ago. However, we
compiled a set of DFTD single-base substitutions enriched for
somatic mutations by identifying variants that were present in
one DFTD genome but absent in the other. We identified
15,160 single-base substitutions that were present in 87T but
not 53T, and 17,790 that were in 53T but absent from 87T
(Figure 2B). These variants could have arisen as somatic base
substitution mutations. Alternatively, as we do not know the
germline genotype of the DFTD founder devil, they could have
been heterozygous germline variants that were lost in either of
the two DFTD lineages. However, we established that most of
these variants are likely to have arisen as somatic substitutions
by demonstrating the absence of 15 out of 16 in the genomes
of 110 normal devils. Moreover, the nonsynonymous to synony-
mous (NS/S) ratios for the 87T and 53T unique variants were
2.78 and 2.08 respectively, a range typical of somatic variants
in human cancers and compatible with that expected from
random mutagenesis (Figure 4A). By contrast, the NS/S ratios
of germline devil single-nucleotide polymorphisms (SNPs) were
0.9 and 0.98 for the normal male and female devil genomes,
respectively, similar to that of common SNPs in humans and
indicative of substantial negative selection. Finally, as somatic
mutations are likely to arise in the heterozygous state, the
observation that variants unique to each DFTD lineage contain
a high proportion of heterozygous variants provides further
evidence for these sets being strongly enriched for somatic
mutations (Figure 4B).These estimates suggest that 87T and 53T have each acquired
between 15,000 and 17,000 single-base substitution mutations
since divergence from their most recent common ancestor
tumor. We do not know how many somatic mutations were
present in the DFTD lineage prior to 87T and 53T divergence.
However, the observation that the total number of private vari-
ants inferred in the most recent common ancestor tumor
(136,559) is comparable to the number of private variants in
a normal male genome (135,134), as well as the NS/S ratio for
these variants (0.8), suggests that the largemajority of the private
variants in the common ancestor tumor were of germline origin.
This suggests that the prevalence of somatic substitution muta-
tions in DFTD may not be substantially greater than 17,000. This
is somewhat higher than the number of mutations observed in
many human tumor types (approximately 5,000 per cancer
genome) (Greenman et al., 2007). However, it is less than are
found in many human melanomas and lung cancers, which are
often the result of past mutagenic exposures, or in human
cancers with mutator phenotypes due to DNA mismatch repair
defects (Pleasance et al., 2010a, 2010b).
Cancers often have mutational processes that are different to
those which operate in the germline. Comparison of themutation
spectra of Tasmanian devil germline variation to the sets of vari-
ants highly enriched for somatic mutations in 87T and 53T re-
vealed that, as expected, devil germline SNPs were enriched
for transitions (Figure 4C). However, we also observed elevated
proportions of A:T/ T:A, A:T/ C:G, and G:C/ T:A transver-
sion mutations in DFTD (Figure 4C). This pattern was indepen-
dently detectable in 87T and 53T since their divergence from
their most recent common ancestor tumor, but was not detect-
able in the variants inferred in these two tumors’ most recent
common ancestor (Figure 4C). This suggests that this mutation
profile is the result of an endogenous mutational process—for
example, a defect in DNA repair—that was acquired before the
divergence of the two lineages, or that it was caused by indepen-
dent exposure of the two lineages to a carcinogenic environ-
mental agent.
Copy number changes and structural rearrangements are
commonly somatically acquired by cancer genomes. Although
the majority of the copy number variants that we identified in
87T and 53T were common to both lineages (Figure S3), some
copy number variants, including, for example, the hemizygous
deletion on chromosome 3 in 87T, occurred in only one of the
two tumors (Figure 4D). Such variants are likely to have arisen
since the divergence of the 87T and 53T tumor lineages and
have therefore been somatically acquired during DFTD evolu-
tion. We identified and validated 11 and 17 rearrangements
that were specific to the 87T and 53T DFTD genomes, respec-
tively (Figure 4E and Table S3). Thirteen of the 28 rearrange-
ments unique to either 87T or 53T had between two and six
bases of microhomology at the breakpoint region, indicating
that DFTD may employ microhomology-mediated end joining
as a repair process for double-stranded DNA breaks.
Most of the somatic variants that are present in DFTD are likely
to be selectively neutral passengermutations. However, a subset
of somatic variants in the DFTD genome will be driver mutations
that have provided selective advantage to the cancer during
passage through its devil hosts. Three hundred twenty-fourCell 148, 780–791, February 17, 2012 ª2012 Elsevier Inc. 785
Figure 4. Somatic Evolution of DFTD
(A) Nonsynonymous to synonymous ratios for variants occurring in genes in DFTD and in normal devil genomes and for variants inferred in the most recent
common ancestor tumor of 87T and 53T (the progenitor). Only variants that were unique to the respective genomes were included in the analysis. Non-
synonymous gene variants in DFTD are listed in Table S4.
(B) Heterozygosity for variants unique to the normal male genome, DFTD genomes and inferred in the most recent common ancestor tumor of 87T and 53T (the
progenitor).
(C) Mutation spectrum of single-base substitutions in DFTD and normal devil genomes. Only variants that were unique to the specified sample(s) were included in
the analysis. The spectrum and ratios of the most recent common ancestor (progenitor) tumor (which includes the germline variants of the founder devil) were
calculated using the common variants between 87T and 53T that were not present in the normal devil genomes.
(D) Copy number analysis of Tasmanian devil chromosome 3 in 53T and 87T. Each dot represents the log2 ratio (that falls within the range 2 to +2) between
the number of sequence reads in the tumor genome and the number of sequence reads in the female normal genome that align within a 2 kb genomic window.
If p < 13 105, the dot is red; otherwise, dots are gray. Homozygous variants unique to either 53T or 87T are shown as black dots above the copy number plot.
See Figure S3 for genome-wide comparison of 87T and 53T copy number.
(E) Structural variants unique to 87T and 53T. Each chromosome is represented by a colored bar and black lines indicate either large-scale rearrangements
(connecting lines) or small-scale rearrangements (single lines). Three 87T rearrangements that occurred close together on chromosome 2 are represented with
a single bar (*). See Table S3 for rearrangement coordinates.
See also Figure S3 and Tables S3 and S4.genes were predicted to contain nonsynonymous substitution
and indel variants that were present in 87T and 53T but not in
either of the normal devil genomes (Table S4). These included
313 genes with single-base substitutions and 11 genes with
indels. A search for predicted nonsynonymous mutations in
a set of 138 genes that are known to be mutated by single-
base substitutions and indels in human cancers (Futreal et al.,
2004) yielded heterozygous single-base substitutions in RET
and FANCD2 that were not present in either of the two normal786 Cell 148, 780–791, February 17, 2012 ª2012 Elsevier Inc.genomes that we sequenced. Both mutations were predicted
to cause single base substitution mutations that have not previ-
ously been described in cancer (Table S4).
Changes in the copy number of cancer genes and truncation
or fusion of genes through rearrangements can also promote
oncogenesis. Two genes, MAST3 and a novel gene with simi-
larity to BTNL9, were predicted to be homozygously deleted in
DFTD. The functions of these two genes are not well understood,
although the butyrophilin gene family, of which the BTNL9-like
gene is a member, may be involved in immune modulation
(Arnett et al., 2009; Stammers et al., 2000). Neither of the
DFTD genomes contained any predicted regions of high-level
amplification (Figure S3). We found several putative rearrange-
ments involving genes, including a balanced translocation
involving PDGFA (Table S4).
Although DFTD is not virally transmitted, it is possible that
a virus may have contributed to DFTD pathogenesis. We
searched for the presence of virus DNA in DFTD by aligning
virus-derived DNA sequences contained in the RefSeq database
with the assembled DFTD genomes as well as the normal devil
genome assembly. We did not find evidence for exogenous
viruses in the DFTD genome. However, it is possible that DFTD
contains viral sequences that were not detectable using this
method.
DFTDcolonizes its devil hosts as an allogeneic graft. In order to
investigate themechanismswherebyDFTD evades host immune
rejection,we searched for genetic variants in 25genes involved in
the antigen processing and presentation machinery (described
by gene ontology IDs GO:0019885 and GO:0019882). Fifteen of
these genes could be identified in the devil genome, and one
gene, NOD1, had a predicted rearrangement that was predicted
to be present in both DFTD genomes but absent from the normal
Tasmanian devil genomes (Table S4). Further analysis and
annotation of immune genes in the Tasmanian devil genome
will be required to elucidate the genetic mechanisms of DFTD
immune evasion.
Divergence and Clonal Dynamics of DFTD Lineages
We have described the somatic changes that have occurred in
two DFTD cancers, 87T and 53T, collected in the Forestier
Peninsula in the southeast of Tasmania and Narawntapu
National Park on the north coast of Tasmania, respectively, since
divergence from their most recent common ancestor tumor.
Observational epidemiological studies have indicated that
DFTD first arrived in the Forestier Peninsula in 2004. The first
DFTD case observed in Narawntapu National Park was in
2007. However, we do not know the routes that were followed
by these lineages across Tasmania, nor do we have any informa-
tion about the clonal dynamics of DFTD disease spread. We
investigated whether DFTD progression into new territories is
characterized by linear colonization and occupation, or rather
by repeated waves of lineage replacement.
The evolutionary dynamics of the DFTD clone during its
expansion across Tasmania can be traced by analysis of the
observed patterns of somatic mutation. We collected 104
DFTD tumors from 69 Tasmanian devils captured in several loca-
tions throughout Tasmania between 2004 and 2010 (Figure 5).
We genotyped this set of tumors for 16 variants that we had
previously identified either in 87T or 53T but not in both tumors
and thus are likely to be somatic (Table S5). In addition, we
analyzed the mitochondrial genomes (excluding the control
region) from the entire set of DFTD tumors, leading to the identi-
fication of 21 somatic mitochondrial DFTD variants (Table S5).
These experiments revealed differences in the population of
DFTD in different regions of Tasmania.
The observation that all of the tumors in the isolated Forestier
Peninsula cluster into a single lineage suggests that this tumorpopulation was founded by a single subclone of DFTD, precur-
sors of which are located on the east coast of Tasmania (Fig-
ure 5). Divergence within this lineage after its introduction has
given rise to a number of tumor subclones found only within
the Forestier Peninsula. One of these lineages (illustrated in Fig-
ure 5 with a green dot, black outline) appears to have increased
in frequency between 2007 and 2010 in a manner resembling
a selective sweep (Figure 5, lower panel). These fluctuations in
the dominant tumor type could be due to selection, or they could
alternatively be due to simple neutral processes.
In contrast to the Forestier Peninsula, themainland Tasmanian
DFTD population shows the emergence and simultaneous
maintenance of several distinct tumor subclones (Figure 5).
The tumor lineage to which 53T belongs appears to be a
dominant clone in the north and northwest (Figure 5, dots with
green outline). Several tumors were found to have unique
patterns of variation. For example, each of the two tumors that
we sampled from northeastern Tasmania, the location where
DFTD was first observed in 1996, had their own individual
patterns of variation (Figure 5, orange and black dots, gray
outline), suggesting that tumor diversity may be greater in this
region, perhaps reflecting its status as the possible origin of
DFTD (Hawkins et al., 2006).
DFTD Diversity within Individual Hosts
We collected two or more DFTD tumors from 20 individual devils
in our set. In some cases the additional tumorswere facial or oral,
and in others they were in submandibular lymph nodes and
internal organs. Genotyping was unable to distinguish between
multiple tumors derived from the same host in 14 of the 20 cases,
suggesting that most additional tumors are metastases of
primary tumors originating from a single DFTD bite.
There were six cases, however, in which an individual animal
had tumors with two different genotypes (Figure S4). In three of
these cases, both genotypes were found in tumors in other
animals, indicating that the two tumors were probably derived
from separate DFTD bites. This suggests that prior exposure
to DFTD does not protect devils from subsequent DFTD inocu-
lations. However, in each of the remaining three cases, one of
the two genotypes was not found in a tumor in any of the other
animals that we sampled. In these instances, the two genotypes
differed only by a single variant, and it is possible that the novel
genotypes may have arisen as new variants in these animals
(Figure S4).
DISCUSSION
Cancer genomes bear imprints of carcinogenic exposures,
endogenous DNA repair processes and selective pressures to
which the clone has been subject. DFTD has existed as a malig-
nant clonal lineage for at least 15 years by repeated subcloning
through the Tasmanian devil population. Our analysis of the
genomes of two geographically distant DFTD subclones has
indicated that DFTD is continuing to acquire new variations in
its karyotype, genomic copy number and DNA sequence.
Despite evidence for ongoing somatic change in the DFTD
lineage, the overall level of mutation that has been accrued by
two DFTD lineages since divergence from their most recentCell 148, 780–791, February 17, 2012 ª2012 Elsevier Inc. 787
Figure 5. DFTD Clonal Dynamics
Phylogenetic tree summarizing genetic variation found in 104 DFTD tumors collected from 69 Tasmanian devils. The tree was constructed using both nuclear and
mitochondrial variants and branch length represents the number of variants (either nuclear or mitochondrial) that distinguish each tumor type from the most likely
ancestral tumor type (solid gray). Trapping locations for devils captured with DFTD are indicated either on themap of Tasmania (top) or on themap of the Forestier
Peninsula (bottom), with colors indicating the genetic subgroup to which each animal’s tumor(s) belongs. Four Forestier Peninsula tumors for which trapping
location data were not available are indicated in boxes. The six cases in which a single devil hadmultiple tumors with more than one genotype are represented on
the map with just one genotype. See also Figure S4 for further details about devils with multiple tumors and Table S5 for genome coordinates for variants.common ancestor tumor is comparable with the number of
changes that are observed within some human cancers (Pleas-
ance et al., 2010a, 2010b). This is perhaps surprising, given
that DFTD has probably undergone a greater number of mitoses
than most human cancers. It indicates, however, that DFTD
is a relatively stable lineage and that a high level of genomic
instability has not been required for the cancer to become
transmissible.
Analysis of the genetic diversity of DFTD subclones
throughout mainland Tasmania suggests that the evolution of
DFTD has been characterized by linear radiation of DFTD
subtypes from their common origin. Geographical analysis of
DFTD lineage diversity indicates a wide distribution of variant
DFTD subclones as well as local coexistence of different
subclones, sometimes even within a single host. Our analysis
identified a DFTD founder population on an isolated peninsula.
Divergence within this lineage has led to the appearance of
several DFTD subtypes, one of which has recently become
dominant in a manner resembling a selective sweep. Future788 Cell 148, 780–791, February 17, 2012 ª2012 Elsevier Inc.genomic analysis of hundreds of DFTD genomes will provide
further insight into the diversity and evolution of DFTD, and
may perhaps help to predict the future trajectory of this clone
and its impact on the devil population.
The transfer of cancer cells between individuals is normally
prevented both by physical barriers and by the action of the
immune system. The ability of transmissible cancers to circum-
vent these obstacles demonstrates the potential of cancer
cells to become parasitic clonal lineages. DFTD and CTVT are
the only two known naturally occurring transmissible clonal
lineages. Our studies have highlighted similarities and differ-
ences between the two lineages. Previous reports have indi-
cated that the most recent common ancestor of today’s globally
distributed CTVT clones existed between 47 and 2,000 years
ago (Murgia et al., 2006; Rebbeck et al., 2009). DFTD, however,
is probably not more than 20 years old. CTVT has been observed
to periodically take up mitochondria from its host by horizontal
transfer (Rebbeck et al., 2011); in contrast, we do not find any
evidence for this phenomenon in DFTD. Interestingly, it has
been proposed that many modern CTVT tumors represent the
most recent global sweep of a subclone of the disease (Rebbeck
et al., 2009). We observed a similar sweep of DFTD tumors on
the Forestier Peninsula. Both CTVT and DFTD continue to
acquire new copy number variations (Thomas et al., 2009).
Future analysis of both the DFTD and CTVT lineages and their
hosts will help to determine the common and unique features
of these two cancers and will perhaps reveal common genetic
changes that favor the outgrowth and progression of clonally
transmissible cancers.
Although there are no known naturally occurring transmissible
cancers that affect humans, there are rare reports of cancer
transmission between two or more humans. These involve
accidental transfer of cancer cells through organ transplantation
or during surgical procedures, deliberate transfer of cancer
cells between humans for experimental purposes, or transfer
of cancer cells in utero (Gandhi and Strong, 2007; Ga¨rtner
et al., 1996; Moore et al., 1957; Tolar and Neglia, 2003). Further
comparative studies of transmissible cancer genomes may indi-
cate the mechanisms that permit cancer transmission between
individuals.
Cancer is an inevitable outcome of the potential of cells to
reproduce and to adapt to their environment; their environment
is usually limited to a single host, but cancers can sometimes
escape from their hosts and become parasitic clonal lineages.
Here we have described a whole-genome analysis of such
a cancer, and our studies have provided insights into the genetic
identity of the individual that founded the DFTD clone, as well as
patterns of ongoing DFTD somatic evolution and clonal
dynamics. This work will enable more detailed studies of the
structure and history of the Tasmanian devil population and
its response to the DFTD epidemic. Understanding the interac-
tion between the genomes of DFTD and its host and the identifi-
cation of patterns of disease spread and host response may
provide information that will assist with the conservation of the
Tasmanian devil.
EXPERIMENTAL PROCEDURES
Whole-Genome Sequencing, Assembly, and Annotation
DNA from a female Tasmanian devil fibroblast cell line (with trisomy 6) and from
two DFTD cell lines (87T and 53T) was extracted and used to prepare short
insert libraries and mate pair libraries with insert sizes from 3–10 kb (fibroblast
cell line only) for paired end sequencing as previously described (Bentley et al.,
2008). Short-insert library sequencing with 100 bp paired-end reads was
performed on an Illumina HiSeq2000 instrument and mate-pair library
sequencing with 50 bp paired-end reads was performed on an Illumina GA2
instrument. In addition, short-insert libraries were constructed from DNA ex-
tracted from the liver of a male Tasmanian devil. The library was sequenced
on an Illumina Genome Analyzer IIx machine with 108 bp reads. Sequencing,
raw data processing, and quality-control checks were performed as previously
described (Bentley et al., 2008).
The genome of the female devil was assembled with the Phusion2 Assembly
Pipeline (Mullikin and Ning, 2003). In brief, paired-end sequence reads were
processed to generate kmer words (k = 61). K-tuples were merged and sorted
into a table, and shared kmer words were linked in a relation matrix. Small
read clusters with 100,000 reads were used to generate contigs with Phrap
(http://www.phrap.com/). RPono, a package in the Phusion2 pipeline, was
then used to build supercontigs with mate-pair sequences. Genome size
was estimated using kmer frequency information, flow karyotype analysis
and nuclear DNA content analysis (see the Extended Experimental Proce-dures, Figure S1, and Table S1). The genome was annotated with the Ensembl
Genebuild Pipeline (Curwen et al., 2004; Potter et al., 2004). Transcriptome
sequencing of pooled RNA from 12 devil tissues was used to assist with
annotation (more details are in the Extended Experimental Procedures).
Chromosome Assignment
Each of the seven Tasmanian devil chromosomes was individually sorted from
the female devil fibroblast cell line with a flow cytometer. Fifty thousand copies
of each devil chromosome were collected, amplified, and sequenced on two
lanes of an Illumina Genome Analyzer IIx instrument with 100 bp paired-end
reads. Alignment of chromosome-derived reads with contigs was used to
assign contigs to chromosomes and to correct assembly errors. We assigned
35,534 supercontigs (99%) to individual chromosomes (Table S2). Supercon-
tigs were ordered on chromosomes using conservation with opossum, and
supercontigs that could not be assigned to a chromosome were assigned to
‘‘ChrU.’’ Chromosome assignment was validated with fluorescence in situ
hybridization. Sorted chromosomes were also used as probes for chromo-
some painting (Extended Experimental Procedures).
Variant Analysis
Reads were aligned with the reference genome using BWA (Li and Durbin,
2009). Single-base substitutions (Figure 2B) were called using SAMtools and
filtered by coverage (minimum 10, maximum 150), read quality (minimum
quality, 30), mapping quality (minimum quality, 30), base quality (minimum
quality, 30), and end of contig (minimum distance to end of contig, 500 bp).
Indels (Figure 2B) were called using CASAVA with parameters Q(snp) R 30
and Q(max_gtype)R 5. One hundred eleven of 117 (95%) single-base substi-
tutions and 119 of 124 (96%) indels, randomly selected, were confirmed with
capillary sequencing. Variants from each genome were compared and sub-
tracted to identify the set of variants that were unique to each genome.
Structural rearrangements were identified as previously described (Pleas-
ance et al., 2010a). In brief, read pairs were aligned with the draft Tasmanian
devil assembly with BWA (Li and Durbin, 2009). Discordant pairs that mapped
with an unexpected insert distance or orientation or to different supercontigs
were identified and clustered to form regions of interest. We discarded groups
which did not have at least seven reads of mapping quality R30 supporting
the variant, as well as all reads that were within 500 bp of the end of a contig.
Structural variants were filtered for those that were specific to individual
samples and a subset were validated with PCR, gel electrophoresis, and
sequencing from both ends with an ABI 3730xl DNA analyzer. Mitochondrial
genomes (excluding the control region) were sequenced with the capillary
platform, and variants were called with NovoSNP (Weckx et al., 2005). Copy
number variants were identified using the DNAcopy package (Olshen et al.,
2004) with a nonoverlapping window of 2,000 bp. A subset of copy number
variants were validated with quantitative real-time PCR.
Tasmanian Devil Samples
Tissue samples were collected from wild and captive Tasmanian devils under
research authorities 33/2004-2005 and 24/2006-2008 (extended) issued by
the Tasmanian Department of Primary Industries, Water, and the Environment.
The research was reviewed by the Wellcome Trust Sanger Institute Animal
Ethics Committee.
ACCESSION NUMBERS
The Tasmanian devil mitochondrial genome has been deposited at DDBJ/
EMBL/GenBank under accession JN216828. This Whole Genome Shotgun
project has been deposited at DDBJ/EMBL/GenBank under the accession
AEFK00000000. The version described in this paper is the first version,
AEFK01000000. The genome can be accessed on Ensembl at http://www.
ensembl.org/Sarcophilus_harrisii/.
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